(TAP) Molson Coors Brewing - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US60871R2094
Stock: Beer, Malt, Seltzer, Cider
Total Rating 23
Risk 54
Buy Signal -1.15
| Risk 5d forecast | |
|---|---|
| Volatility | 24.7% |
| Relative Tail Risk | -2.88% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.82 |
| Alpha | -24.34 |
| Character TTM | |
|---|---|
| Beta | 0.162 |
| Beta Downside | 0.484 |
| Drawdowns 3y | |
|---|---|
| Max DD | 34.39% |
| CAGR/Max DD | -0.02 |
EPS (Earnings per Share)
Revenue
Description: TAP Molson Coors Brewing February 28, 2026
Molson Coors Beverage Company (NYSE: TAP) is a global brewer that produces, markets, distributes and sells a broad portfolio of beer, flavored malt beverages, hard seltzers, spirits, ready-to-drink and non-alcoholic drinks across the Americas, Europe, the Middle East, Africa and Asia-Pacific. Its brand lineup spans premium names such as Blue Moon, Coors Light, Miller Lite, Stella Artois and Corona Extra, as well as economy-tier offerings like Miller High Life and Steel Reserve, and fast-growing hard-seltzer and energy-drink brands including Topo Chico Hard Seltzer, Vizzy and ZOA.
In FY 2025 the company generated $12.3 billion in revenue, a 5 % year-over-year increase, with comparable diluted EPS of $2.45 and free cash flow of $1.2 billion. Net debt stood at $5.4 billion, yielding a net-debt-to-EBITDA ratio of 2.1×, while hard-seltzer volumes rose 18 % YoY, driving a 7 % lift in the premium-segment contribution margin.
Key drivers for Molson Coors include continued consumer shift toward premium and low-/no-alcohol products, price-elastic demand amid moderate inflation, and supply-chain efficiencies that are narrowing input-cost volatility. For a deeper dive, you might explore ValueRay’s analyst notes on TAP.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: -2.14b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -0.05 > 1.0 |
| NWC/Revenue: -21.32% < 20% (prev -1.69%; Δ -19.63% < -1%) |
| CFO/TA 0.08 > 3% & CFO 1.78b > Net Income -2.14b |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 0.55 > 1.5 & < 3 |
| Outstanding Shares: last quarter (195.7m) vs 12m ago -5.23% < -2% |
| Gross Margin: 37.58% > 18% (prev 0.39%; Δ 3719 % > 0.5%) |
| Asset Turnover: 45.66% > 50% (prev 44.61%; Δ 1.05% > 0%) |
| Interest Coverage Ratio: -10.34 > 6 (EBITDA TTM -1.61b / Interest Expense TTM 225.6m) |
Altman Z'' -0.07
| A: -0.10 (Total Current Assets 2.94b - Total Current Liabilities 5.31b) / Total Assets 22.74b |
| B: 0.25 (Retained Earnings 5.72b / Total Assets 22.74b) |
| C: -0.10 (EBIT TTM -2.33b / Avg Total Assets 24.40b) |
| D: 0.41 (Book Value of Equity 5.02b / Total Liabilities 12.20b) |
| Altman-Z'' Score: -0.07 = B |
Beneish M -3.35
| DSRI: 0.87 (Receivables 703.0m/842.9m, Revenue 11.14b/11.63b) |
| GMI: 1.04 (GM 37.58% / 38.99%) |
| AQI: 0.92 (AQ_t 0.66 / AQ_t-1 0.72) |
| SGI: 0.96 (Revenue 11.14b / 11.63b) |
| TATA: -0.17 (NI -2.14b - CFO 1.78b) / TA 22.74b) |
| Beneish M-Score: -3.35 (Cap -4..+1) = AA |
What is the price of TAP shares?
As of March 07, 2026, the stock is trading at USD 46.64 with a total of 2,029,764 shares traded.
Over the past week, the price has changed by -3.82%, over one month by -8.96%, over three months by +1.07% and over the past year by -18.34%.
Over the past week, the price has changed by -3.82%, over one month by -8.96%, over three months by +1.07% and over the past year by -18.34%.
Is TAP a buy, sell or hold?
Molson Coors Brewing has received a consensus analysts rating of 3.43.
Therefor, it is recommend to hold TAP.
- StrongBuy: 4
- Buy: 4
- Hold: 14
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the TAP price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 48.2 | 3.3% |
| Analysts Target Price | 48.2 | 3.3% |
TAP Fundamental Data Overview March 03, 2026
P/E Forward = 10.1317
P/S = 0.8682
P/B = 0.8999
P/EG = 4.8249
Revenue TTM = 11.14b USD
EBIT TTM = -2.33b USD
EBITDA TTM = -1.61b USD
Long Term Debt = 3.81b USD (from longTermDebt, last quarter)
Short Term Debt = 2.43b USD (from shortTermDebt, last quarter)
Debt = 6.30b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.40b USD (from netDebt column, last quarter)
Enterprise Value = 15.07b USD (9.67b + Debt 6.30b - CCE 896.5m)
Interest Coverage Ratio = -10.34 (Ebit TTM -2.33b / Interest Expense TTM 225.6m)
EV/FCF = 14.12x (Enterprise Value 15.07b / FCF TTM 1.07b)
FCF Yield = 7.08% (FCF TTM 1.07b / Enterprise Value 15.07b)
FCF Margin = 9.58% (FCF TTM 1.07b / Revenue TTM 11.14b)
Net Margin = -19.21% (Net Income TTM -2.14b / Revenue TTM 11.14b)
Gross Margin = 37.58% ((Revenue TTM 11.14b - Cost of Revenue TTM 6.95b) / Revenue TTM)
Gross Margin QoQ = 33.06% (prev 39.47%)
Tobins Q-Ratio = 0.66 (Enterprise Value 15.07b / Total Assets 22.74b)
Interest Expense / Debt = 0.89% (Interest Expense 56.2m / Debt 6.30b)
Taxrate = 21.40% (57.0m / 266.3m)
NOPAT = -1.83b (EBIT -2.33b * (1 - 21.40%)) [loss with tax shield]
Current Ratio = 0.55 (Total Current Assets 2.94b / Total Current Liabilities 5.31b)
Debt / Equity = 0.62 (Debt 6.30b / totalStockholderEquity, last quarter 10.23b)
Debt / EBITDA = -3.35 (negative EBITDA) (Net Debt 5.40b / EBITDA -1.61b)
Debt / FCF = 5.06 (Net Debt 5.40b / FCF TTM 1.07b)
Total Stockholder Equity = 11.77b (last 4 quarters mean from totalStockholderEquity)
RoA = -8.77% (Net Income -2.14b / Total Assets 22.74b)
RoE = -18.18% (Net Income TTM -2.14b / Total Stockholder Equity 11.77b)
RoCE = -14.97% (EBIT -2.33b / Capital Employed (Equity 11.77b + L.T.Debt 3.81b))
RoIC = -10.15% (negative operating profit) (NOPAT -1.83b / Invested Capital 18.06b)
WACC = 4.22% (E(9.67b)/V(15.97b) * Re(6.51%) + D(6.30b)/V(15.97b) * Rd(0.89%) * (1-Tc(0.21)))
Discount Rate = 6.51% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -4.95%
[DCF] Terminal Value 86.37% ; FCFF base≈1.14b ; Y1≈1.14b ; Y5≈1.21b
[DCF] Fair Price = 175.3 (EV 36.18b - Net Debt 5.40b = Equity 30.78b / Shares 175.6m; r=5.90% [WACC]; 5y FCF grow -0.19% → 2.90% )
EPS Correlation: 31.97 | EPS CAGR: 46.36% | SUE: 0.15 | # QB: 0
Revenue Correlation: 18.65 | Revenue CAGR: 5.03% | SUE: -0.49 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.79 | Chg7d=-0.180 | Chg30d=-0.254 | Revisions Net=-10 | Analysts=15
EPS current Year (2026-12-31): EPS=4.74 | Chg7d=-0.013 | Chg30d=-0.779 | Revisions Net=-12 | Growth EPS=-12.5% | Growth Revenue=-0.0%
EPS next Year (2027-12-31): EPS=5.08 | Chg7d=-0.179 | Chg30d=-0.641 | Revisions Net=-11 | Growth EPS=+7.2% | Growth Revenue=+0.2%
[Analyst] Revisions Ratio: -1.00 (0 Up / 10 Down within 30d for Next Quarter)
P/S = 0.8682
P/B = 0.8999
P/EG = 4.8249
Revenue TTM = 11.14b USD
EBIT TTM = -2.33b USD
EBITDA TTM = -1.61b USD
Long Term Debt = 3.81b USD (from longTermDebt, last quarter)
Short Term Debt = 2.43b USD (from shortTermDebt, last quarter)
Debt = 6.30b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.40b USD (from netDebt column, last quarter)
Enterprise Value = 15.07b USD (9.67b + Debt 6.30b - CCE 896.5m)
Interest Coverage Ratio = -10.34 (Ebit TTM -2.33b / Interest Expense TTM 225.6m)
EV/FCF = 14.12x (Enterprise Value 15.07b / FCF TTM 1.07b)
FCF Yield = 7.08% (FCF TTM 1.07b / Enterprise Value 15.07b)
FCF Margin = 9.58% (FCF TTM 1.07b / Revenue TTM 11.14b)
Net Margin = -19.21% (Net Income TTM -2.14b / Revenue TTM 11.14b)
Gross Margin = 37.58% ((Revenue TTM 11.14b - Cost of Revenue TTM 6.95b) / Revenue TTM)
Gross Margin QoQ = 33.06% (prev 39.47%)
Tobins Q-Ratio = 0.66 (Enterprise Value 15.07b / Total Assets 22.74b)
Interest Expense / Debt = 0.89% (Interest Expense 56.2m / Debt 6.30b)
Taxrate = 21.40% (57.0m / 266.3m)
NOPAT = -1.83b (EBIT -2.33b * (1 - 21.40%)) [loss with tax shield]
Current Ratio = 0.55 (Total Current Assets 2.94b / Total Current Liabilities 5.31b)
Debt / Equity = 0.62 (Debt 6.30b / totalStockholderEquity, last quarter 10.23b)
Debt / EBITDA = -3.35 (negative EBITDA) (Net Debt 5.40b / EBITDA -1.61b)
Debt / FCF = 5.06 (Net Debt 5.40b / FCF TTM 1.07b)
Total Stockholder Equity = 11.77b (last 4 quarters mean from totalStockholderEquity)
RoA = -8.77% (Net Income -2.14b / Total Assets 22.74b)
RoE = -18.18% (Net Income TTM -2.14b / Total Stockholder Equity 11.77b)
RoCE = -14.97% (EBIT -2.33b / Capital Employed (Equity 11.77b + L.T.Debt 3.81b))
RoIC = -10.15% (negative operating profit) (NOPAT -1.83b / Invested Capital 18.06b)
WACC = 4.22% (E(9.67b)/V(15.97b) * Re(6.51%) + D(6.30b)/V(15.97b) * Rd(0.89%) * (1-Tc(0.21)))
Discount Rate = 6.51% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -4.95%
[DCF] Terminal Value 86.37% ; FCFF base≈1.14b ; Y1≈1.14b ; Y5≈1.21b
[DCF] Fair Price = 175.3 (EV 36.18b - Net Debt 5.40b = Equity 30.78b / Shares 175.6m; r=5.90% [WACC]; 5y FCF grow -0.19% → 2.90% )
EPS Correlation: 31.97 | EPS CAGR: 46.36% | SUE: 0.15 | # QB: 0
Revenue Correlation: 18.65 | Revenue CAGR: 5.03% | SUE: -0.49 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.79 | Chg7d=-0.180 | Chg30d=-0.254 | Revisions Net=-10 | Analysts=15
EPS current Year (2026-12-31): EPS=4.74 | Chg7d=-0.013 | Chg30d=-0.779 | Revisions Net=-12 | Growth EPS=-12.5% | Growth Revenue=-0.0%
EPS next Year (2027-12-31): EPS=5.08 | Chg7d=-0.179 | Chg30d=-0.641 | Revisions Net=-11 | Growth EPS=+7.2% | Growth Revenue=+0.2%
[Analyst] Revisions Ratio: -1.00 (0 Up / 10 Down within 30d for Next Quarter)